Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00539_DB01035_nanopub.RAk4Uzv2eIk7vOa3EW1I5kwTLipxaWBitTSLqdTIn6JHg#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00539_DB01035 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00539_DB01035 label "DDI between Toremifene and Procainamide - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Consider alternate therapy. A thorough risk:benefit assessment is required prior to co-administration. [drugbank_resource:DB00539_DB01035]" assertion.
- drugbank_resource:DB00539_DB01035 identifier "drugbank_resource:DB00539_DB01035" assertion.
- drugbank_resource:DB00539_DB01035 title "DDI between Toremifene and Procainamide - Additive QTc-prolongation may occur, increasing the risk of serious ventricular arrhythmias. Consider alternate therapy. A thorough risk:benefit assessment is required prior to co-administration." assertion.
- drugbank:DB01035 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00539_DB01035 assertion.
- drugbank:DB00539 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00539_DB01035 assertion.